BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37881879)

  • 1. Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study.
    Lia K; Jørgensen RRK; L Wold B; Fluge Ø; Fagerli UM; Bersvendsen H; Bø IB; Bhargava S; Fosså A
    Haematologica; 2024 May; 109(5):1403-1412. PubMed ID: 37881879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006).
    Eloranta S; Lambert PC; Sjöberg J; Andersson TM; Björkholm M; Dickman PW
    J Clin Oncol; 2013 Apr; 31(11):1435-41. PubMed ID: 23439756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of Patients With Second Primary Hodgkin Lymphoma.
    Budnik J; Doucette C; Milano MT; Constine LS
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):316-323.e2. PubMed ID: 32014390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials.
    Favier O; Heutte N; Stamatoullas-Bastard A; Carde P; Van't Veer MB; Aleman BM; Noordijk EM; Thomas J; Fermé C; Henry-Amar M;
    Cancer; 2009 Apr; 115(8):1680-91. PubMed ID: 19208428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
    Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
    J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.
    Minn AY; Riedel E; Halpern J; Johnston LJ; Horning SJ; Hoppe RT; Goodman KA
    Br J Haematol; 2012 Nov; 159(3):329-39. PubMed ID: 22966754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009.
    Sjöberg J; Halthur C; Kristinsson SY; Landgren O; Nygell UA; Dickman PW; Björkholm M
    Blood; 2012 Jan; 119(4):990-6. PubMed ID: 22147892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.
    Rosenberg AS; Klein AK; Ruthazer R; Evens AM
    Am J Hematol; 2016 Jun; 91(6):560-5. PubMed ID: 26928381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Patel CG; Michaelson E; Chen YH; Silver B; Marcus KJ; Stevenson MA; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):498-506. PubMed ID: 29153331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
    de Vries S; Schaapveld M; Janus CPM; Daniëls LA; Petersen EJ; van der Maazen RWM; Zijlstra JM; Beijert M; Nijziel MR; Verschueren KMS; Kremer LCM; van Eggermond AM; Lugtenburg PJ; Krol ADG; Roesink JM; Plattel WJ; van Spronsen DJ; van Imhoff GW; de Boer JP; Aleman BMP; van Leeuwen FE
    J Natl Cancer Inst; 2021 Jun; 113(6):760-769. PubMed ID: 33351090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.
    Sickinger MT; von Tresckow B; Kobe C; Engert A; Borchmann P; Skoetz N
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010533. PubMed ID: 25572491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
    Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
    Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
    BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
    Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
    Arthritis Res Ther; 2019 Jun; 21(1):154. PubMed ID: 31238961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental longevity and survival in elderly patients with Hodgkin's lymphoma.
    Landgren O; Askling J; Dickman PW; Osby E; Axdorph U; Ekbom A; Björkholm M
    Haematologica; 2002 Jun; 87(6):596-601. PubMed ID: 12031915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.
    Metser U; Prica A; Hodgson DC; Mozuraitis M; Eberg M; Mak V; Green B; Singnurkar A; Dudebout J; MacCrostie P; Tau N; Mittmann N; Langer DL
    Radiology; 2019 Feb; 290(2):488-495. PubMed ID: 30511907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up.
    Liu L; Giusti F; Schaapveld M; Aleman B; Lugtenburg P; Meijnders P; Hutchings M; Lemmens V; Bogaerts J; Visser O
    Br J Haematol; 2017 Jan; 176(1):65-75. PubMed ID: 27766636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
    Reedijk AMJ; Zijtregtop EAM; Coebergh JWW; Meyer-Wentrup FAG; Hebeda KM; Zwaan CM; Janssens GOR; Pieters R; Plattel WJ; Dinmohamed AG; Zijlstra JM; Kremer LCM; Lugtenburg PJ; Beishuizen A; Karim-Kos HE
    Br J Haematol; 2020 Jun; 189(6):1093-1106. PubMed ID: 32030738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Survival of Patients With Hodgkin Lymphoma Over 4 Decades: Experience of the British National Lymphoma Investigation (BNLI) With 6834 Patients.
    Kwan A; Chadwick N; Hancock B
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):108-119. PubMed ID: 28027894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
    Székely E; Lindén O; Peterson S; Jerkeman M
    Eur J Haematol; 2016 Oct; 97(4):393-8. PubMed ID: 26872557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.